Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank50
3Y CAGR-3.0%
5Y CAGR+37.3%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-3.0%/yr
Annual compound
5Y CAGR
+37.3%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
4.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $430.34M | -23.4% |
| 2023 | $562.03M | +1.5% |
| 2022 | $553.46M | +17.3% |
| 2021 | $472.02M | +29.1% |
| 2020 | $365.56M | +314.3% |
| 2019 | $88.23M | +115.2% |
| 2018 | $41.00M | - |